Evidence map›Paper›PMID 28825964›Full record

ArticleAnalytical chemistry2017

Fabrication of an Open Microfluidic Device for Immunoblotting.

Philippe Abdel-Sayed, Kevin A Yamauchi, Rachel E Gerver, Amy E Herr

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Analytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Philippe Abdel-SayedDepartment of Bioengineering, University of California Berkeley , Berkeley, California 94720, United States.ORCID 0000-0002-6054-0573
Kevin A YamauchiDepartment of Bioengineering, University of California Berkeley , Berkeley, California 94720, United States.
Rachel E GerverDepartment of Bioengineering, University of California Berkeley , Berkeley, California 94720, United States.
Amy E HerrDepartment of Bioengineering, University of California Berkeley , Berkeley, California 94720, United States.
University of California, Berkeley · US

Funding

Microfluidic Western Blotting for Targeted Proteomic Analysis of Single Circulating Tumor CellsR21CA183679 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI HERR, AMY ELIZABETH · 2015 to 2017
$634k
Measuring biophysical & protein signaling indicators of invasion potential in single-circulating tumor cellsR21EB019880 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI HERR, AMY ELIZABETH · 2015 to 2016
$464k
NCI NIH HHS R21 CA183679NIBIB NIH HHS R21 EB019880
6 · The paper itself

Abstract

Given the wide adoption of polydimethylsiloxane (PDMS) for the rapid fabrication of microfluidic networks and the utility of polyacrylamide gel electrophoresis (PAGE), we develop a technique for fabrication of PAGE molecular sieving gels in PDMS microchannel networks. In developing the fabrication protocol, we trade-off constraints on materials properties of these two polymer materials: PDMS is permeable to O

Indexed as

Microfluidic Analytical TechniquesAdoptionAnimalsCattleDimethylpolysiloxanesElectrophoresis, Polyacrylamide GelImmunoblottingOvalbuminParticle SizeSerum Albumin, BovineTrypsin InhibitorsbaysilonDimethylpolysiloxanesOvalbuminSerum Albumin, BovineTrypsin Inhibitors

Identifiers

PMID28825964
PMCPMC6275090
OpenAlexW2746347611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.